Tocilizumab for treating mevalonate kinase deficiency and TNF receptor-associated periodic syndrome: a case series and literature review
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Tocilizumab for treating mevalonate kinase deficiency and TNF receptor-associated periodic syndrome: a case series and literature review ; volume:22 ; number:1 ; day:5 ; month:1 ; year:2024 ; pages:1-10 ; date:12.2024
Pediatric rheumatology ; 22, Heft 1 (5.1.2024), 1-10, 12.2024
- Creator
-
Li, Yandie
Lu, Meiping
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12969-023-00952-2
- URN
-
urn:nbn:de:101:1-2024031822043524699040
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Li, Yandie
- Lu, Meiping
- SpringerLink (Online service)
Other Objects (12)
A Pilot Study on Tocilizumab for Treating Refractory Adult-Onset Still’s Disease
![Effekte einer Tocilizumab-Therapie auf die Knochendichte, Marker des Knochenstoffwechsels und Aktivitätsparameter bei TNF-α [TNF-alpha] vortherapierter aktiver rheumatoider Arthritis](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Effekte einer Tocilizumab-Therapie auf die Knochendichte, Marker des Knochenstoffwechsels und Aktivitätsparameter bei TNF-α [TNF-alpha] vortherapierter aktiver rheumatoider Arthritis
Tuberculosis in otherwise healthy adults with inherited TNF deficiency
Publisher Correction: A Pilot Study on Tocilizumab for Treating Refractory Adult-Onset Still’s Disease
Iron Sucrose: A Wealth of Experience in Treating Iron Deficiency
Deficiency of PPP6C protects TNF-induced necroptosis through activation of TAK1
Tocilizumab-Induced Erythema Annulare Centrifugum
A pro‐inflammatory signalome is constitutively activated by C33Y mutant TNF receptor 1 in TNF receptor‐associated periodic syndrome (TRAPS)
A phase II trial protocol of Tocilizumab in anti-TNF refractory patients with JIA-associated uveitis (the APTITUDE trial)
Evaluation of infliximab/tocilizumab versus tocilizumab among COVID-19 patients with cytokine storm syndrome
Clinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patients with inadequate response to anti-TNF monoclonal antibodies
Tocilizumab : erstes zugelassenes Biologikum bei Riesenzellarteriitis
A Pilot Study on Tocilizumab for Treating Refractory Adult-Onset Still’s Disease
Effekte einer Tocilizumab-Therapie auf die Knochendichte, Marker des Knochenstoffwechsels und Aktivitätsparameter bei TNF-α [TNF-alpha] vortherapierter aktiver rheumatoider Arthritis
Tuberculosis in otherwise healthy adults with inherited TNF deficiency
Publisher Correction: A Pilot Study on Tocilizumab for Treating Refractory Adult-Onset Still’s Disease
Iron Sucrose: A Wealth of Experience in Treating Iron Deficiency
Deficiency of PPP6C protects TNF-induced necroptosis through activation of TAK1
Tocilizumab-Induced Erythema Annulare Centrifugum
A pro‐inflammatory signalome is constitutively activated by C33Y mutant TNF receptor 1 in TNF receptor‐associated periodic syndrome (TRAPS)
A phase II trial protocol of Tocilizumab in anti-TNF refractory patients with JIA-associated uveitis (the APTITUDE trial)
Evaluation of infliximab/tocilizumab versus tocilizumab among COVID-19 patients with cytokine storm syndrome
Clinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patients with inadequate response to anti-TNF monoclonal antibodies
Tocilizumab : erstes zugelassenes Biologikum bei Riesenzellarteriitis
A Pilot Study on Tocilizumab for Treating Refractory Adult-Onset Still’s Disease
Effekte einer Tocilizumab-Therapie auf die Knochendichte, Marker des Knochenstoffwechsels und Aktivitätsparameter bei TNF-α [TNF-alpha] vortherapierter aktiver rheumatoider Arthritis
Tuberculosis in otherwise healthy adults with inherited TNF deficiency
Publisher Correction: A Pilot Study on Tocilizumab for Treating Refractory Adult-Onset Still’s Disease
Iron Sucrose: A Wealth of Experience in Treating Iron Deficiency
Deficiency of PPP6C protects TNF-induced necroptosis through activation of TAK1
Tocilizumab-Induced Erythema Annulare Centrifugum
A pro‐inflammatory signalome is constitutively activated by C33Y mutant TNF receptor 1 in TNF receptor‐associated periodic syndrome (TRAPS)
A phase II trial protocol of Tocilizumab in anti-TNF refractory patients with JIA-associated uveitis (the APTITUDE trial)
Evaluation of infliximab/tocilizumab versus tocilizumab among COVID-19 patients with cytokine storm syndrome
Clinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patients with inadequate response to anti-TNF monoclonal antibodies